Cardiovascular risk and dyslipidemia among persons living with HIV: a review.

ABSTRACT:

Background

Aim of this review is to focus the attention on people living with HIV infection at risk of developing a cardiovascular event. What is or what would be the most suitable antiretroviral therapy? Which statin or fibrate to reduce the risk? How to influence behavior and lifestyles?

Discussion

Prevention of cardiovascular disease (CVD) risk remains the first and essential step in a medical intervention on these patients. The lifestyle modification, including smoking cessation, increased physical activity, weight reduction, and the education on healthy dietary practices are the main instruments. Statins are the cornerstone for the treatment of hypercholesterolemia. They have been shown to slow the progression or promote regression of coronary plaque, and could also exe

SUBMITTER: Maggi P 

PROVIDER: S-EPMC5550957 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature